Can Glucarpidase Help Reverse Methotrexate Kidney Damage?January 9, 2025Mixed TopicsB Cell LymphomaHodgkin LymphomaMantle Cell LymphomaALLAggressive LymphomasAML
New Cancer Drugs: Do Patients Prefer Faster Access or Clinical Benefit?December 12, 2024Patient & Survivor CareMixed TopicsDLBCLBusiness of MedicineAggressive LymphomasAMLALL
High-Fiber Diet Linked to Improved Stem Cell Transplant, GvHD OutcomesDecember 9, 2024TransplantPatient & Survivor CareALLCLLNon-Hodgkin LymphomaMyelodysplastic SyndromeMixed Topics
ASH 2024: New Leukemia Txs, Fewer Blood Clots With GLP-1 RxsDecember 9, 2024ALLCLLBleeding DisordersThrombosis
Inside the Patient-Oncologist Bond: Why It’s Often So StrongDecember 2, 2024Patient & Survivor CareMixed TopicsDLBCLMultiple MyelomaAMLAggressive LymphomasALL
For Radiation ‘Downwinders,’ Cancer Compensation Is On HoldOctober 25, 2024Patient & Survivor CareNon-Hodgkin LymphomaMultiple MyelomaDLBCLCMLALLAML
Popular Weight Loss Drugs Now for Patients With Cancer?September 30, 2024Patient & Survivor CareDLBCLAggressive LymphomasALLAMLB Cell LymphomaCLL
Does Medicare Advantage Offer Higher-Value Chemotherapy?September 26, 2024Patient & Survivor CareMixed TopicsBusiness of MedicineALLAggressive LymphomasAMLB Cell Lymphoma
AACR Cancer Progress Report: Big Strides and Big GapsSeptember 26, 2024Patient & Survivor CareDiversity in MedicineDLBCLMixed TopicsPediatricsAggressive LymphomasALL
Cancer Risk: Are Pesticides the New Smoking?September 20, 2024Patient & Survivor CareALLAMLAggressive LymphomasB Cell LymphomaBusiness of MedicineCLL
Do Clonal Hematopoiesis and Mosaic Chromosomal Alterations Increase Solid Tumor Risk?September 6, 2024Patient & Survivor CareAggressive LymphomasALLAMLB Cell LymphomaCLLCML
